| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Experience Onward Partners with Enthea to Expand Access to Psilocybin Treatment Through a Medical Tourism Benefit | 90 | Newsfile | Portland, Oregon--(Newsfile Corp. - April 2, 2025) - Experience Onward, Oregon's premier state-licensed psilocybin service center, is proud to announce its partnership with Enthea, the nation's first... ► Artikel lesen | |
| 27.03. | Psilocybin und Co: Rausch für die Seele | 1 | DAZ.online | ||
| 26.03. | Compass Pathways plc: Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression | 225 | Business Wire | Highlights: Screening closed for all sites and final participants being scheduled for dosing On track for top-line 6-week primary endpoint results in late Q2
Compass Pathways plc (Nasdaq:... ► Artikel lesen | |
| 19.03. | Experience Onward: New Psilocybin Service Center Opens to Support Athletes, Veterans, and Others with Traumatic Brain Injuries | 273 | Newsfile | Portland, Oregon--(Newsfile Corp. - March 19, 2025) - Oregon's newest licensed psilocybin service center, Experience Onward opened in December of 2024, to provide a space for those seeking healing... ► Artikel lesen | |
| 18.03. | Compass Pathways plc: Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression | 336 | Business Wire | Highlights: 52-week observational follow-up study from Phase 2b reveals single 25 mg COMP360 psilocybin dose offers longer-term antidepressant effects compared to lower doses, with average... ► Artikel lesen | |
| 09.03. | Unterschiedliche Auswirkungen von Psilocybin auf das mentale Wohlbefinden je nach ethnischer Zugehörigkeit | 3 | IT BOLTWISE | ||
| 05.03. | Psilocybin can tackle brain injuries and binge eating, and these ASX companies are in the game | 1 | Stockhead | ||
| 21.01. | Filament Health Announces Shipment Of Botanical Psilocybin To The University Of Wisconsin-madison | 1 | CNW | ||
| 21.01. | RUA BIOSCIENCE LIMITED: Psilocybin clinical trial update | 2 | NZX | ||
| 16.01. | Kaya Holdings, Inc.: The Sacred Mushroom, Oregon's Premier Psilocybin Treatment Center Introduces "Synergy by Design" Journey Customization Program | 357 | ACCESS Newswire | PORTLAND, OR / ACCESS Newswire / January 16, 2025 / Kaya Holdings, Inc. (OTCQB:KAYS) and The Sacred Mushroom ("TSM"), Portland's one-of-a-kind psilocybin treatment center today announced the launch... ► Artikel lesen | |
| 13.01. | Optimi Health Corp: Optimi Health exports psilocybin extract to New Zealand | 2 | Stockwatch | ||
| 13.01. | Optimi Health Corp.: Optimi Health Reports First Patients Dosed in Landmark Natural Psilocybin Study in New Zealand | 208 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - January 13, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of psychedelic... ► Artikel lesen | |
| 02.01. | Linderung psychischer Belastungen: Studie: Psilocybin als Palliativtherapie | 2 | APOTHEKE ADHOC | ||
| 28.12.24 | Psilocybin: Potenzial für verbesserte Schlafqualität bei Depressionen | - | IT BOLTWISE | ||
| 28.12.24 | Psilocybin: Ein Hoffnungsträger in der Depressionsbehandlung? | - | IT BOLTWISE | ||
| 23.12.24 | Kaya Holdings, Inc. and the Sacred Mushroom Psilocybin Treatment Facility Announce Inaugural Open House and New Series of Low-Dose Psilocybin Sessions | 369 | ACCESS Newswire | PORTLAND, OR / ACCESSWIRE / December 23, 2024 / Kaya Holdings, Inc. (OTCQB:KAYS) and The Sacred MushroomTM, Portland's one-of-a-kind psilocybin treatment center, are excited to announce their first... ► Artikel lesen | |
| 20.12.24 | Avextra AG: Avextra Backs Landmark Psilocybin Therapy Study in Palliative Care | 683 | Dow Jones News | Press Release: Avextra Backs Landmark Psilocybin Therapy Study in Palliative Care
News Release
-- Exclusive Industry Role: Avextra is the industry partner in a
groundbreaking project... ► Artikel lesen | |
| 18.12.24 | Positive interim results for Tryptamine's trial of oral psilocybin to treat IBS | 6 | Stockhead | ||
| 17.12.24 | Optimi Health Corp.: Optimi Health to Supply GMP-Certified Psilocybin for Psyence Biomed's Phase IIb Palliative Care Trial | 317 | Newsfile | Agreement Supports Phase IIb and Future Phase III Trial Development,Addressing Critical Needs in Palliative Care Using Optimi's Natural Psilocybin ExtractVancouver, British Columbia--(Newsfile Corp.... ► Artikel lesen | |
| 06.12.24 | Portland Launches Nation's First Psilocybin Service Center Combining Mindfulness Practices | 2 | Benzinga.com |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| TESLA | 3.371 |
| NVIDIA | 2.650 |
| RHEINMETALL | 1.751 |
| RENK GROUP | 1.548 |
| THYSSENKRUPP | 1.462 |
| BAYER | 1.438 |
| STEYR MOTORS | 1.427 |
| BYD | 1.351 |
| NEL | 1.268 |
| DEUTZ | 1.252 |
| TUI | 1.186 |
| VOLKSWAGEN | 1.077 |
| EVOTEC | 1.027 |
| NOVO NORDISK | 1.018 |
| MERCEDES-BENZ | 885 |
| XIAOMI | 845 |
| PORSCHE AG | 758 |
| AMAZON | 740 |
| BASF | 691 |
| COMMERZBANK | 682 |
| DEUTSCHE BANK | 668 |
| NORDEX | 657 |
| PUMA | 655 |
| AIXTRON SE | 607 |
| MUTARES | 543 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
